Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

This update describes a Phase 2 clinical trial evaluating IMVT-1402 for efficacy, safety, and tolerability in adults with active, difficult-to-treat rheumatoid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• IMVT-1402

Snippet

Sponsor: Immunovant Sciences GmbH | Conditions: Rheumatoid Arthritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING